Chemed Corporation (CHE) Earnings History
Annual and quarterly earnings data from 1989 to 2025
Loading earnings history...
CHE EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
CHE Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 30.0% | 13.4% | 10.5% |
| 2024 | 35.1% | 15.1% | 12.4% |
| 2023 | 35.3% | 15.0% | 12.0% |
| 2022 | 35.8% | 16.1% | 11.7% |
| 2021 | 36.0% | 16.0% | 12.6% |
Download Data
Export CHE earnings history in CSV or JSON format
Free sign-in required to download data
Chemed Corporation (CHE) Earnings Overview
As of May 7, 2026, Chemed Corporation (CHE) reported trailing twelve-month net income of $260M, reflecting -7.4% year-over-year growth. The company earned $19.00 per diluted share over the past four quarters, with a net profit margin of 10.5%.
Looking at the long-term picture, CHE's 5-year EPS compound annual growth rate (CAGR) stands at -1.1%, signaling declining earnings. The company achieved its highest annual net income of $319M in fiscal 2020.
Chemed Corporation maintains positive profitability with a gross margin of 30.0%, operating margin of 13.4%, and net margin of 10.5%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including ADUS ($100M net income, 6.7% margin), ENSG ($363M net income, 6.8% margin), SCI ($626M net income, 12.6% margin), CHE has outperformed on profitability metrics. Compare CHE vs ADUS →
CHE Earnings vs Peers
Earnings metrics vs comparable public companies
CHE Historical Earnings Data (1989–2025)
37 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $265M | -12.2% | $338M | $18.42 | 10.5% | 13.4% |
| 2024 | $302M | +10.8% | $366M | $19.89 | 12.4% | 15.1% |
| 2023 | $273M | +9.2% | $341M | $17.93 | 12.0% | 15.0% |
| 2022 | $250M | -7.0% | $343M | $16.53 | 11.7% | 16.1% |
| 2021 | $269M | -15.9% | $343M | $16.85 | 12.6% | 16.0% |
| 2020 | $319M | +45.3% | $390M | $19.48 | 15.4% | 18.7% |
| 2019 | $220M | +7.0% | $257M | $13.31 | 11.3% | 13.3% |
| 2018 | $206M | +109.4% | $244M | $12.23 | 11.5% | 13.7% |
| 2017 | $98M | -9.7% | $113M | $5.86 | 5.9% | 6.8% |
| 2016 | $109M | -1.4% | $179M | $6.48 | 6.9% | 11.3% |
See CHE's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CHE Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CHE vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCHE — Frequently Asked Questions
Quick answers to the most common questions about buying CHE stock.
Is CHE growing earnings?
CHE EPS fell to $19.00, with earnings declining -7.4%. This contrasts with the 5-year CAGR of -1.1%. TTM net income dropped to $260M.
What are CHE's profit margins?
Chemed Corporation net margin is +10.5%, with operating margin at +13.4%. Margins sit within typical range for the sector.
How consistent are CHE's earnings?
CHE earnings data spans 1989-2025. The declining earnings trend is -7.4% YoY. Historical data enables comparison across business cycles.